Advanced Search

Home > Journals > Minerva Ginecologica > Past Issues > Minerva Ginecologica 2015 April;67(2) > Minerva Ginecologica 2015 April;67(2):217-23

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEMINERVA GINECOLOGICA

A Journal on Obstetrics and Gynecology

Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index

Frequency: Bi-Monthly

ISSN 0026-4784

Online ISSN 1827-1650

 

Minerva Ginecologica 2015 April;67(2):217-23

    REVIEWS

New paradigms in PCOS: impaired glucose tolerance and cardiovascular risk. Clinical approach

Ravn P.

Department of Gynecology and Obstetrics, Odense University Hospital, Odense, Denmark

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder amongst women of reproductive age and is associated with various metabolic risk factors, in addition to chronic anovulation and factors related to androgen excess. Women with PCOS have a higher risk of insulin resistance, hyperinsulinemia, glucose intolerance, dyslipidemia, and an increased prothrombotic state, resulting in a higher risk of type 2 diabetes mellitus, subclinical atherosclerosis, vascular dysfunction, and apparently cardiovascular disease and mortality. The aim of the present article was to summarize current knowledge with focus on a suggestion to the clinical approach and handling of these metabolic risk factors.

language: English


FULL TEXT  REPRINTS

top of page